0001062993-14-006903.txt : 20141125
0001062993-14-006903.hdr.sgml : 20141125
20141125165618
ACCESSION NUMBER: 0001062993-14-006903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141121
FILED AS OF DATE: 20141125
DATE AS OF CHANGE: 20141125
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Toby
CENTRAL INDEX KEY: 0001405128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 141250305
MAIL ADDRESS:
STREET 1: 4092 BOCAIRE BLVD.
CITY: BOCA RATON
STATE: FL
ZIP: 33487
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2014-11-21
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001405128
Wegman Toby
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2014-11-21
4
M
0
15000
17
A
16714
D
Common Stock, $0.001 par value
2014-11-21
4
S
0
10000
39.0369
D
6714
D
Common Stock, $0.001 par value
2014-11-24
4
S
0
2050
39.2590
D
4664
D
Stock Option (Right to Buy)
17
2014-11-21
4
M
0
15000
0
D
2018-06-24
Common Stock, $0.001 par value
15000
0
D
The selling price of $39.0369 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.00 to $39.10. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The selling price of $39.2590 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.25 to $39.62. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The options vested monthly with respect to 1/12 of the total number of shares until all shares underlying the option fully vested.
/s/Toby Wegman by Carl A. Valenstein, attorney- in-fact
2014-11-25